Yvonne Bouter

1.6k total citations
38 papers, 1.2k citations indexed

About

Yvonne Bouter is a scholar working on Physiology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Yvonne Bouter has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Physiology, 18 papers in Cellular and Molecular Neuroscience and 14 papers in Pharmacology. Recurrent topics in Yvonne Bouter's work include Alzheimer's disease research and treatments (25 papers), Neuroscience and Neuropharmacology Research (12 papers) and Cannabis and Cannabinoid Research (8 papers). Yvonne Bouter is often cited by papers focused on Alzheimer's disease research and treatments (25 papers), Neuroscience and Neuropharmacology Research (12 papers) and Cannabis and Cannabinoid Research (8 papers). Yvonne Bouter collaborates with scholars based in Germany, United Kingdom and Canada. Yvonne Bouter's co-authors include Thomas A. Bayer, Caroline Bouter, Julius N. Meißner, Oliver Wirths, Katharina Dietrich, Nicola Beindorff, Sascha Weggen, Thierry Pillot, Claus U. Pietrzik and Roosmarijn E. Vandenbroucke and has published in prestigious journals such as Journal of Clinical Investigation, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Yvonne Bouter

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yvonne Bouter Germany 18 727 319 297 271 238 38 1.2k
Sadim Jawhar Germany 6 741 1.0× 278 0.9× 288 1.0× 236 0.9× 164 0.7× 6 968
Shoko Hashimoto Japan 15 825 1.1× 480 1.5× 309 1.0× 394 1.5× 164 0.7× 34 1.4k
Naomi Mihira Japan 7 972 1.3× 491 1.5× 334 1.1× 407 1.5× 178 0.7× 12 1.3k
Jian–Zhi Wang China 20 867 1.2× 759 2.4× 389 1.3× 281 1.0× 249 1.0× 39 1.7k
Hiroki Sasaguri Japan 14 737 1.0× 547 1.7× 267 0.9× 316 1.2× 147 0.6× 32 1.3k
Simon Gengler United Kingdom 10 874 1.2× 444 1.4× 458 1.5× 352 1.3× 159 0.7× 11 1.4k
Katherine R. Sadleir United States 12 850 1.2× 488 1.5× 234 0.8× 255 0.9× 256 1.1× 21 1.3k
Elisabetta Lauretti United States 18 585 0.8× 523 1.6× 205 0.7× 192 0.7× 237 1.0× 26 1.3k
Walter Gulisano Italy 20 747 1.0× 562 1.8× 396 1.3× 268 1.0× 336 1.4× 27 1.3k
Nathalie Pierrot Belgium 21 881 1.2× 641 2.0× 396 1.3× 238 0.9× 217 0.9× 30 1.4k

Countries citing papers authored by Yvonne Bouter

Since Specialization
Citations

This map shows the geographic impact of Yvonne Bouter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvonne Bouter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvonne Bouter more than expected).

Fields of papers citing papers by Yvonne Bouter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvonne Bouter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvonne Bouter. The network helps show where Yvonne Bouter may publish in the future.

Co-authorship network of co-authors of Yvonne Bouter

This figure shows the co-authorship network connecting the top 25 collaborators of Yvonne Bouter. A scholar is included among the top collaborators of Yvonne Bouter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvonne Bouter. Yvonne Bouter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bouter, Caroline, et al.. (2025). Chronic exposure to a synthetic cannabinoid improves cognition and increases locomotor activity in Tg4-42 Alzheimer's disease mice. Journal of Alzheimer s Disease Reports. 9. 4123423378–4123423378.
2.
Bouter, Yvonne, et al.. (2025). 18F-FDG-PET and Multimodal Biomarker Integration: A Powerful Tool for Alzheimer’s Disease Diagnosis. Nuclear Medicine and Molecular Imaging. 59(6). 453–471. 1 indexed citations
3.
Schmitt, F., et al.. (2024). The synthetic cannabinoid WIN 55,212-2 attenuates cognitive and motor deficits and reduces amyloid load in 5XFAD Alzheimer mice. Pharmacology Biochemistry and Behavior. 247. 173944–173944. 2 indexed citations
4.
5.
Bouter, Caroline, et al.. (2023). Chronic exposure to a synthetic cannabinoid alters cerebral brain metabolism and causes long-lasting behavioral deficits in adult mice. Journal of Neural Transmission. 130(8). 1013–1027. 4 indexed citations
6.
Bouter, Yvonne, et al.. (2022). Donanemab detects a minor fraction of amyloid-β plaques in post-mortem brain tissue of patients with Alzheimer’s disease and Down syndrome. Acta Neuropathologica. 143(5). 601–603. 17 indexed citations
7.
Bayer, Thomas A., et al.. (2022). Ablation of the Presynaptic Protein Mover Impairs Learning Performance and Decreases Anxiety Behavior in Mice. International Journal of Molecular Sciences. 23(19). 11159–11159. 2 indexed citations
8.
Bakrania, Preeti, Yvonne Bouter, Caroline Bouter, et al.. (2021). Discovery of a novel pseudo β-hairpin structure of N-truncated amyloid-β for use as a vaccine against Alzheimer’s disease. Molecular Psychiatry. 27(2). 840–848. 21 indexed citations
9.
Bouter, Caroline, et al.. (2021). Quantitative Brain Positron Emission Tomography in Female 5XFAD Alzheimer Mice: Pathological Features and Sex-Specific Alterations. Frontiers in Medicine. 8. 745064–745064. 16 indexed citations
10.
Bouter, Yvonne, et al.. (2020). miRNA Alterations Elicit Pathways Involved in Memory Decline and Synaptic Function in the Hippocampus of Aged Tg4-42 Mice. Frontiers in Neuroscience. 14. 580524–580524. 6 indexed citations
11.
12.
Bouter, Yvonne, Magdalena M. Brzózka, Rafał Ryguła, et al.. (2019). Chronic Psychosocial Stress Causes Increased Anxiety-Like Behavior and Alters Endocannabinoid Levels in the Brain of C57B l /6J Mice. Cannabis and Cannabinoid Research. 5(1). 51–61. 21 indexed citations
13.
Bouter, Yvonne, et al.. (2019). Prolonged Cannabidiol Treatment Lacks on Detrimental Effects on Memory, Motor Performance and Anxiety in C57BL/6J Mice. Frontiers in Behavioral Neuroscience. 13. 94–94. 41 indexed citations
14.
Bouter, Caroline, et al.. (2019). 18F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4–42 Model of Alzheimer’s Disease. Frontiers in Aging Neuroscience. 10. 425–425. 52 indexed citations
15.
Beindorff, Nicola, et al.. (2019). Analysis of Motor Function in the Tg4-42 Mouse Model of Alzheimer’s Disease. Frontiers in Behavioral Neuroscience. 13. 107–107. 49 indexed citations
16.
Bayer, Thomas A., et al.. (2019). Reduced Acoustic Startle Response and Prepulse Inhibition in the Tg4-42 Model of Alzheimer’s Disease. Journal of Alzheimer s Disease Reports. 3(1). 269–278. 10 indexed citations
17.
López‐Noguerola, José Sócrates, et al.. (2018). Synergistic Effect on Neurodegeneration by N-Truncated Aβ4−42 and Pyroglutamate Aβ3−42 in a Mouse Model of Alzheimer's Disease. Frontiers in Aging Neuroscience. 10. 64–64. 12 indexed citations
18.
Bouter, Yvonne, Birgit Meller, Bettina Wolf, et al.. (2018). Immunohistochemical detection of chemokine receptor 4 expression in chronic osteomyelitis confirms specific uptake in 68Ga-Pentixafor-PET/CT. Nuklearmedizin - NuclearMedicine. 57(5). 198–203. 7 indexed citations
19.
Bouter, Yvonne, Tim Kacprowski, Robert Weißmann, et al.. (2014). Deciphering the Molecular Profile of Plaques, Memory Decline and Neuron Loss in Two Mouse Models for Alzheimer’s Disease by Deep Sequencing. Frontiers in Aging Neuroscience. 6. 75–75. 70 indexed citations
20.
Saiepour, Nasrin, Yvonne Bouter, Bernhard Clemens Richard, et al.. (2013). N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody. Acta Neuropathologica Communications. 1(1). 56–56. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sadim Jawhar Breakdown of academic impact, for papers by Shoko Hashimoto Breakdown of academic impact, for papers by Naomi Mihira Breakdown of academic impact, for papers by Jian–Zhi Wang Breakdown of academic impact, for papers by Hiroki Sasaguri Breakdown of academic impact, for papers by Simon Gengler Breakdown of academic impact, for papers by Katherine R. Sadleir Breakdown of academic impact, for papers by Elisabetta Lauretti Breakdown of academic impact, for papers by Walter Gulisano Breakdown of academic impact, for papers by Nathalie Pierrot
Rankless by CCL
2026